SPAST and hereditary spastic paraplegia: In summary, our findings suggest that the mut SPAST protein may perform a dominant-negative effect, which is the first clinical pedigree to confirm truncated spastin that interferes with normal protein function, providing an alternative pathological mechanism for HSP.